Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

SyntheticMRs software solution SyMRI receives regulatory approval in Brazil

SyntheticMR announced today that their quantitative imaging software solution SyMRI has received regulatory approval in Brazil and can now be sold on this market.“We are ecstatic to bring our SyMRI software to the Brazilian market,” says Kyle Frye, President SyntheticMR Inc. “We know there are many healthcare providers that are excited to utilize our technology to speed up their current workflow and add additional information to aid in upfront diagnosis.  To be able to sell within Brazil opens up abundant opportunities for SyntheticMR Inc. It also means that combined with our previous

vacancy rate unchanged in June

Vacancy rate at 2020-07-01 was 7.8 percent,which is the same as at 2020-06-01. Rent collection for June was 2 percentage points lower than normal. During first half of 2020 vacancy rate decreased 0.9 percentage points,from 8.7 percent to 7.8 percent.Net letting during the period was 365 apartments.   Berlin, 2020-07-08  Ralf SpannCEO+49 173 643 65 90ralf.spann@akelius.de (ralf.spann@akelius.de%0d) Akelius Residential Property AB’s D-shares are listed on Nasdaq First North Growth Market Stockholm.Avanza Bank is the Certified Adviser of the company, ca@avanza.

Positive trend continues for Citycon in July

CITYCON OYJ   Press release 8 July 2020Citycon continues to show positive development in footfall despite the extraordinary circumstances following the outbreak of the Covid-19 pandemic. Overall, the total footfall for week 27 was tracking at over 90% compared to 2019. Additionally, Norway outperformed last year’s footfall results with an index of 105% versus prior year. Estonia also showed a slight increase versus prior year footfall levels. - It is encouraging to see more customers coming to our centres in Norway than last year and that all our countries are returning to normal

Metso Outotec technology chosen to help increase grinding capacity of Boliden Harjavalta’s slag concentrator

Metso Outotec Corporation press release, July 08, 2020 at 10:00 am EESTBoliden Harjavalta has chosen Metso Outotec’s SMD grinding mills to improve the capacity of its slag concentrator. Boliden Harjavalta sustainably produces high-quality metals for European industrial customers. In 2019, the company produced 120,000 tonnes of copper and 26,000 tonnes of nickel. The purpose of the slag concentrator is to recover copper from the slag produced in the copper smelter and to return it to the copper production cycle as high-quality slag concentrate. Grinding is an essential part of the slag

Q2 2020 results conference call

Nordic Entertainment Group will publish its Q2 2020 financial results at 07:30 CET on Wednesday 22 July and will hold a conference call at 09:00 CET on the same day. The call will be hosted by Anders Jensen (President & CEO) and Gabriel Catrina (CFO). In order to participate, please call: Sweden:        +46 (0) 8 506 921 80UK:                +44 (0) 8 445 718 892US:                +1 6 315 107 495 The access code for the call is: 8594032. Please call in at least 5 minutes before the scheduled start time so that the conference begins on time. The conference call will also

Data to be presented at ISTH Virtual Congress highlights Sobi's commitment to advancing rare haematolog y treatments

Sobi™  will present data at the ISTH Virtual Congress (International Society on Thrombosis and Haemostasis), 12 – 14 July 2020, strengthening evidence for the efficacy and safety of Elocta® (efmoroctocog alfa) and Alprolix® (eftrenonacog alfa), for haemophilia A and B respectively, as well as pharmacokinetic data on BIVV001 (rFVIIIFc-VWF-XTEN). Data for Doptelet® (avatrombopag) in treatment for thrombocytopenia within Chronic Liver Disease (CLD) and Chronic Immune Thrombocytopenia (ITP) will be presented. Final data in previously untreated patients with haemophilia

Kesko strengthens its position in Norway – acquires building and home improvement trade operator Carlsen Fritzøe Handel

Kesko Corporation's subsidiary Byggmakker Handel AS has agreed to acquire Carlsen Fritzøe Handel AS, a Norwegian operator in the building and home improvement trade with net sales of approximately €201 million in 2019. The acquisition strengthens Kesko’s position in one of the most attractive geographic areas in Norway, the Oslo fjord region, where the Carlsen Fritzøe Handel network of 25 stores highly complements the Byggmakker store network. This transaction is the fourth Kesko has made in line with its growth strategy in Norway in two years to accelerate its growth and strengthen its

The Nomination Committee’s proposal for Board of Directors in Clas Ohlson

The Clas Ohlson Nomination Committee today announces its proposal for the Board of Directors’ composition ahead of the Clas Ohlson AB Annual General Meeting on Saturday 12 September 2020.The Board of Directors shall consist of eight members. The Nomination Committee proposes re-election of the Board members Kenneth Bengtsson, Mathias Haid, Håkan Lundstedt, Charlotte Strömberg, Göran Sundström and Anne Thorstvedt Sjöberg. Margareta Lehman and Göran Näsholm will not be standing for re-election. The Nomination Committee proposes that Mengmeng Du and Patrik Hofbauer be elected as new Board

Nel ASA: (corr) Employee Share Option Program

(Updated with correct number of shares for Bjørn Simonsen and titles for certain employees)   (Oslo, 8 July 2020) Nel ASA (the Company) today has resolved to grant options to all employees of the Company that fulfill the requirements for participation in the employee share option plan. The grant of options is based on the authorization from Nel's annual general meeting of 13 May 2020 to issue new shares in connection with Nel's incentive plan for employees, and the same annual general meeting's adoption of the statement of the board regarding long term incentive plans. A total of

Cyxone signs agreement with Professor Rikard Holmdahl as Senior Scientific Advisor

Cyxone (publ), a Swedish biotech in autoimmune diseases, announces today that the company has engaged Professor Rikard Holmdahl as Senior Scientific Advisor for the company’s projects in autoimmune diseases.Professor Holmdahl brings extensive experience and expertise in the field of immunology and autoimmune diseases. He holds a medical degree and PhD in immunology from Uppsala University and has held several senior scientific positions within academia. In 1990 he was appointed Associate Professor at the Swedish Medical Research Council, and in 1993 he set up the Medical Inflammation

BioStock: Abliva has strengthened its position during 2020

For Abliva, the first half of the year has meant a continuation of the process that began in autumn 2019, when the company decided to focus its work on primary mitochondrial diseases. In 2020, its position has also been strengthened through a rights issue and the addition of well-regarded life science investor Hadean Ventures to the owner list. BioStock contacted CEO Erik Kinnman to hear more about the past six months and what he expects from the rest of 2020.Read the full interview at biostock.se: https://www.biostock.se/en/abliva-has-strengthened-its-position-during-2020/ This is a

Qlife hires Jakob Broberg Lind as Sales Director Clinical

With this role, Qlife is establishing the commercial organization to take the Egoo system to the market and pave the way for the company’s growth. Jakob will take up his position no later than September 1st.Jakob has extensive experience from international sales and business development within MedTech and healthcare and brings an excellent record of results and achievements in complex and competitive business environments. He comes from the role of Nordic Sales Manager & Strategic Account Manager at Boston Scientific. “Qlife has a very strong team with an excellent reputation for

Today, the subscription period starts in SpectrumOne’s rights issue of units

Today, on the 8[th] of July 2020, the subscription period for SpectrumOne AB (“SpectrumOne” or the “Company”) rights issue of units begins. The subscription period runs until the 22[nd] of July 2020. The prospectus, together with other information related to the rights issue of units, are available through the websites of SpectrumOne (www.spectrumone.com) and Sedermera Fondkommission (www.sedermera.se). Subscription of units can be made by submitting a subscription form to Sedermera Fondkommission. Rights issue of units in summary Subscription period: The subscription period in the

Transcom Holding AB (publ): Invitation to Transcom second quarter 2020 results presentation

Transcom are pleased to invite you to their Q2 2020 financial update call on Tuesday, July 21, 2020 at 9:00 CET, following the release of Q2 2020 results at 8:00 am CET. The press release will include a link to the presentation for the call. The materials will also be available on https://www.transcom.com/en/investor-relations. Representing Transcom Jonas Dahlberg, President & CEO Presentation details Date/Time: Tuesday, July 21, 2020 at 9:00 CET Online Registration link: http://emea.directeventreg.com/registration/5574908 Important note: Please register via the link above

Stillfront resolves to allot subscribed shares to the sellers of each of Babil Games, Imperia Online and Playa Games

Press release  2020-07-08Stillfront Group AB (publ) resolves to allot the subscribed shares in the directed new issues of shares to the sellers of Babil Games FZ LLC, Imperia Online JSC and Playa Games GmbH respectively. Babil Games The general meeting in Stillfront resolved on 14 May 2020 on a directed new share issue of not more than 179,217 shares to the sellers of Babil Games, as part of the earn-out consideration to be paid following Stillfront’s acquisition of all of the shares in Babil pursuant to the terms of the acquisition agreement. The earn-out consideration for 2019,

Nel ASA: Employee Share Option Program

(Oslo, 8 July 2020) Nel ASA (the Company) today has resolved to grant options to all employees of the Company that fulfill the requirements for participation in the employee share option plan. The grant of options is based on the authorization from Nel's annual general meeting of 13 May 2020 to issue new shares in connection with Nel's incentive plan for employees, and the same annual general meeting's adoption of the statement of the board regarding long term incentive plans. A total of 12,579,142 share options were granted in a groupwide program comprising all employees in Nel

COVID-19: Ingka Group supports 600,000 people in 30 countries

Since March, IKEA Retail (Ingka Group) has supported over 600,000 people in 30 countries, whose lives have been impacted by the unprecedented coronavirus pandemic.The help and support to the vulnerable groups includes product donations such as complete bedroom and living rooms solutions and other essentials like food, plastic bags, bins and spray bottles and creation of temporary homes and quarantine centers for more than 50,000 homeless people , among others. In March, Ingka Group had

Read original

Invitation to Electrolux Professional AB Q2 2020 presentation

Electrolux Professional AB will publish the Q2 2020 interim report for the period April – June 2020, on Friday 24 July 2020 at 08:00 CET.A telephone conference will be held at 09:00 CET with Alberto Zanata, CEO and Fabio Zarpellon, CFO presenting the result, followed by a Q&A session. The presentation will be available on www.electroluxprofessional.com/corporate.  Please use the following dial-in details to participate in the telephone conference: SE: +46 8 505 583 69 UK: +44 333 300 9261 US: +1 833 526 8396 The telephone conference and presentation can be followed live from

Lynparza approved in the EU for BRCA- mutated metastatic pancreatic cancer

8 July 2020 07:00 BST Lynparza approved in the EU for BRCA-mutated metastatic pancreatic cancer Only PARP inhibitor approved in this disease AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) today announced that Lynparza (olaparib) has been approved in the European Union (EU) for patients with germline BRCA-mutated (gBRCAm) metastatic pancreatic cancer. Pancreatic cancer is a rare, life-threatening disease with the lowest survival rate among the most common cancers.[1] Approximately 5-7% of patients with metastatic

Norway Royal Salmon (NRS): Q2-20 Trading update

Harvested volumes for the second quarter 2020: 7.9 (1.000 gwt) The full Q2 2020 report will be released on 25 August 2020 at 06:30 CET. For further information, please contact:   · CFO Ola Loe, 911 79 411 Norway Royal Salmon in brief The Norway Royal Salmon (NRS) group owns 35 035 tonnes MAB located in Troms and Finnmark. In addition, the group has minority interest in three associated Norwegian fish farming companies which together own 11 fish farming licenses, as well as Arctic Fish on Iceland that has licenses for 11 000 tonnes. NRS is an attractively positioned fish

Kindred Group plc – Trading update for the second quarter 2020

Kindred estimates gross winning revenue for the second quarter of 2020 of about GBP 235 million (Q2-2019: GBP 226.2 million).  Even though cancelled sports events have affected the second quarter, solid growth in revenues from other products has partly compensated. Substantial growth has been delivered by Kindred’s cutting-edge technology, proprietary Racing platform as well as other events such as eSports, and other virtual sports alternatives (e.g. F1, FIFA events). Sports activities have gradually resumed during the latter part of the quarter. It is probable that Kindred and other

Polygiene provides guidance for Q2 compared to the same period last year

Polygiene reports a growth of 37% in the second quarter with a gross margin maintained around 70%. Operating profit after tax improved significantly by SEK -0.9 (-4.3) million over last year.The company provides guidance for the quarterly report released on August 27: · The company reports a sales increase of 37% with a retained gross margin of 70%. Accumulated growth from the beginning of the year amounts to 19%. · Operating profit after tax amounted to SEK -0.9 (-4.3) million, a significant improvement over last year. Excluding the exchange rate effect of a declining dollar,

There are no items matching the current filter
There are no more items matching the current filter
Back to top